Stocktoria
OPKO HEALTH, INC. OPK
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1995-11-02
OPKO HEALTH, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $606.9M | $713.1M | $863.5M | $1.0B | $1.8B |
| Gross profit | $205.9M | $218.5M | $318.1M | $288.2M | — |
| R&D expense | $124.0M | $105.2M | $89.6M | $73.9M | $76.8M |
| SG&A expense | $223.0M | $304.2M | $300.6M | $372.7M | $468.9M |
| Operating income | -$117.4M | -$152.1M | -$157.0M | -$226.3M | $18.8M |
| Interest expense | $0 | — | $13.5M | $12.1M | $18.9M |
| Income tax | -$15.7M | $42.8M | $4.4M | -$63.5M | $15.5M |
| Net income | -$225.7M | -$53.2M | -$188.9M | -$328.4M | -$30.1M |
| EPS (diluted) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 |
| Operating cash flow | -$178.5M | -$183.5M | -$28.2M | -$95.2M | $38.3M |
| Cash & equivalents | $364.4M | $426.6M | $95.9M | $153.2M | $134.7M |
| Inventory | $65.8M | $56.8M | $65.7M | $74.1M | $86.5M |
| Total assets | $1.9B | $2.2B | $2.0B | $2.2B | $2.4B |
| Total liabilities | $664.0M | $834.8M | $622.5M | $605.6M | $714.6M |
| Shareholders' equity | $1.3B | $1.4B | $1.4B | $1.6B | $1.7B |
Source: SEC EDGAR filings · CIK 0000944809 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.